1-3 of 3
Joseph Pariseau, PharmD
Close
Sort by
Journal Articles

A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia

Aaron T. Gerds, MD MS, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Marina Kremyanskaya, Jason R. Gotlib, Jeanne M. Palmer, Kelly McCaul, Vincent Ribrag, Adam J. Mead, MD PhD, Claire N Harrison, Professor, Ruben A Mesa, MD, Jean-Jacques Kiladjian, MD PhD, Giovanni Barosi, Robert Peter Gale, MD PhD DSc, Abderrahmane Laadem, Joseph Pariseau, PharmD, Torsten Gerike, MD, Jennie Zhang, Peter G. Linde, Joseph G. Reynolds, PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 557.
https://doi.org/10.1182/blood-2019-122546
Published: 2019
Journal Articles

Physical Activities in Patients with β-Thalassemia As Measured By Fitbit in Association with Patient-Reported Outcomes

Antonis Kattamis, MD, Pranee Sutcharitchan, MD, Ali Taher, MDPhDFRCP, Maria Domenica Cappellini, MD, Dalia Mahmoud, Joseph Pariseau, PharmD, Abderrahmane Laadem, MD, Anzalee Khan, PhD, X. Henry Hu, MD PhD, Vip Viprakasit, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4731.
https://doi.org/10.1182/blood.V130.Suppl_1.4731.4731
Published: 2017
Journal Articles

Quality of Life in Patients with β-Thalassemia: Transfusion Dependent Versus Non-Transfusion Dependent

Maria Domenica Cappellini, MD, Antonis Kattamis, MD, Vip Viprakasit, MD PhD, Pranee Sutcharitchan, MD, Dalia Mahmoud, Joseph Pariseau, PharmD, Abderrahmane Laadem, MD, Anzalee Khan, PhD, X. Henry Hu, MD PhD, Ali Taher, MDPhDFRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 751.
https://doi.org/10.1182/blood.V130.Suppl_1.751.751
Published: 2017